rs606231276
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_201631.4(TGM5):c.1335G>C(p.Lys445Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000235 in 1,614,048 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000039 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000022 ( 0 hom. )
Consequence
TGM5
NM_201631.4 missense
NM_201631.4 missense
Scores
3
9
3
Clinical Significance
Conservation
PhyloP100: 0.189
Genes affected
TGM5 (HGNC:11781): (transglutaminase 5) This gene encodes a member of the transglutaminase family. The encoded protein catalyzes formation of protein cross-links between glutamine and lysine residues, often resulting in stabilization of protein assemblies. This reaction is calcium dependent. Mutations in this gene have been associated with acral peeling skin syndrome. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
?
Very rare variant in population databases, with high coverage;
PP3
?
MetaRNN computational evidence supports a deleterious effect, 0.916
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TGM5 | NM_201631.4 | c.1335G>C | p.Lys445Asn | missense_variant | 9/13 | ENST00000220420.10 | |
TGM5 | NM_004245.4 | c.1089G>C | p.Lys363Asn | missense_variant | 8/12 | ||
TGM5 | XM_011522230.3 | c.306G>C | p.Lys102Asn | missense_variant | 3/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TGM5 | ENST00000220420.10 | c.1335G>C | p.Lys445Asn | missense_variant | 9/13 | 1 | NM_201631.4 | P1 | |
TGM5 | ENST00000349114.8 | c.1089G>C | p.Lys363Asn | missense_variant | 8/12 | 1 | |||
TGM5 | ENST00000396996.3 | n.811G>C | non_coding_transcript_exon_variant | 2/6 | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.0000394 AC: 6AN: 152138Hom.: 1 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
6
AN:
152138
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000439 AC: 11AN: 250834Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135558
GnomAD3 exomes
AF:
AC:
11
AN:
250834
Hom.:
AF XY:
AC XY:
4
AN XY:
135558
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1461792Hom.: 0 Cov.: 32 AF XY: 0.0000220 AC XY: 16AN XY: 727190
GnomAD4 exome
AF:
AC:
32
AN:
1461792
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
727190
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0000394 AC: 6AN: 152256Hom.: 1 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74456
GnomAD4 genome
?
AF:
AC:
6
AN:
152256
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
?
AF:
AC:
3
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:4Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Acral peeling skin syndrome Pathogenic:3Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Baylor Genetics | - | - - |
Pathogenic, no assertion criteria provided | clinical testing | Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City | Feb 05, 2020 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 07, 2022 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 2009 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 04, 2020 | Although some homozygous control individuals have been reported, these individuals have not been screened for mild skin anomalies and may be mildly affected (Abouelhoda et al., 2016); Published functional studies in a transfected HEK293 epithelial cell line demonstrate a marked reduction in enzyme activity that was approximately 30% of the level in wild type cells (van der Velden et al., 2015); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31589614, 19440220, 21307953, 20164844, 22160262, 27884173, 25644735, 22036214, 30011071) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
Cadd
Benign
Dann
Uncertain
DEOGEN2
Uncertain
T;T;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D
MetaSVM
Uncertain
T
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
Sift4G
Pathogenic
D;D;D;D;D
Polyphen
1.0
.;.;D;.;D
Vest4
0.95, 0.94
MutPred
0.86
.;.;Loss of ubiquitination at K445 (P = 0.0067);.;.;
MVP
MPC
0.69
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at